Delivery order 75F40123F19005KAIVA STRATEGIES, LLC
Overview
Award facts
- Net obligations
- $1.86M
- $1,862,130of $1.86M potential value
- Outlays (paid to date)
- $1.86M
- $1.86M paid of $1.86M obligated$1,862,130
- Period of performance
- Jun 30, 2023 to Aug 5, 2025
- Ended
- Modifications
- 5
- Latest action Jul 13, 2026
- Contract type
- Delivery order
- PIID 75F40123F19005
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
THE CONTRACTOR SHALL PROVIDE SCIENTIFIC WRITERS-EDITORS TO SUPPORT DIVISION OF VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY (DVRPA) STAFF WHO HAVE RESPONSIBILITY FOR REVIEW OF REGULATORY SUBMISSIONS AND PREPARATION OF REVIEW MEMORANDA, ADVISORY
Dates and value
- Award date
- Signed on Jun 30, 2023
- Current value
- $1,862,130Base and exercised options
- Potential value (if all options are exercised)
- $1,862,130
- Parent contract vehicle
- 75F40122D00018 (IDC, single award) — 9 orders recorded under it
Obligations by fiscal year of action
- FY2026: -$257,665 (de-obligation)
- FY2024: $731,234
- FY2023: $1,388,561
Total across 3 fiscal years: $1,862,130
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 13, 2026. View on USAspending · Recipient on SAM.gov
Recipient
Business types and certifications
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Biologics; Coronavirus emergency funding supplementalProgram activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Silver Spring, Montgomery County, Maryland 20993-0003
- Congressional district (place of performance)
- MD-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- B529SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA (service)
Competition
- Extent competed
- Not available for competitionB
- Reason not competed
- Authorized by statute (FAR 6.302-5(A)(2)(I))OTH
- Solicitation procedures
- Only one sourceSSS
- Set-aside
- 8(a) sole source8AN
- Contract pricing
- Labor hoursZ
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jun 30, 2023Base obligation at award: $1,388,561
- Latest action
- Jul 13, 2026 — CloseoutModification P00005; obligation change -$257,665; administrative: no change in scope or value
- Latest substantive action
- Jun 24, 2024 — Option exercisedModification P00002; obligation change +$731,234
- Actions by type
- Base award1
- Other administrative action3
- Option exercised1
- Closeout1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$257,665
- Latest action: change in base and all options
- -$257,665
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Delivery orderC
- Parent vehicle type
- IDCB
- Parent vehicle: multiple or single award
- Single awardS
- Parent vehicle agency
- Food And Drug Administration7524
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 6
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2023/2023-0600-000
- 075-X-0600-000
- Object classes
- 25.6: Medical care
- Disaster or emergency funding (DEFC)
- N: Emergency P.L. 116-136
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
- COVID-19 supplemental obligations
- $1,444,776
- COVID-19 supplemental outlays
- $1,312,106